Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05598879

Global Cardio Oncology Registry

Conditions: Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis, Cardiotoxicity, Cardiovascular Diseases

Sex: All
Ages: 18 Years – N/A
Enrollment: 5000
Sponsor: The Cleveland Clinic

Location: United States

Summary

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.

Eligibility Criteria

Inclusion Criteria:New cardio-oncology consultation for breast cancer patients, orNew cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, orNew cardio-oncology consultation for acute or chronic leukemia patients, orNew cardio-oncology consultation for multiple myeloma or AL amyloidosis, orNew cardio-oncology consultations for immune check-point inhibitors cardiac evaluation.All patients have to be 18 years old or olderExclusion Criteria:Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators.Minors less than 18 years old.Inability or unwillingness to consent to participate

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05598879). StuddyBuddy aggregates publicly available trial information.